Worldwide Robotic Endoscopy Devices Industry to 2026 – Increasing Geriatric Population and Rise in Prevalence of Obesity and Diabetes is Driving Growth – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Robotic Endoscopy Devices Market – Growth, Trends, COVID-19 Impact, and Forecasts (2021 – 2026)” report has been added to ResearchAndMarkets.com’s offering.
The robotic endoscopy devices market was valued at approximately USD 1,576.34 million in 2020 and is expected to witness a revenue of USD 3,222.87 million in 2026, with a CAGR of 12.45% over the forecast period.
Companies Mentioned
- Intuitive Surgical Inc
- Asensus Surgical, Inc
- Johnson and Johnson (Auris Health Inc.)
- Brainlab AG
- Medrobotics Corporation
- Olympus Corporation
- CMR Surgical Ltd
- Avatera Medical GmbH
- AKTORmed GmbH
- Medtronic plc
The outbreak of the COVID-19 pandemic is expected to have a significant impact on the Robotic Endoscopic Devices market. The lockdown measures across the world have resulted in decreased public mobility, as well as impacted the diagnostics and imaging industry significantly, as the diagnostic procedures and screening programs, which are non-immediate, were postponed to decrease the burden on healthcare infrastructure. In the wake of the COVID-19 pandemic, in May 2020, Sixteen experts from the Asian Pacific Society for Digestive Endoscopy (APSDE) developed position statements, including patient triage and risk assessment before endoscopy, resource prioritization and allocation, regular monitoring of personal protective equipment, infection control measures, protective device training and implementation of a strategy for stepwise resumption of endoscopy services after control of the COVID-19 outbreak.
Key Market Trends
Laparoscopy is Expected to Hold the Largest Market Share in the Robotic Endoscopy Devices Market
Laparoscopic procedures are expected to be accountable for the highest market revenue due to a rise in the volume of robotic laparoscopic surgeries with their increased preference and adoption owing to the recent advancements in laparoscopic diagnostics and minimally invasive therapeutic procedures such as digital laparoscopy. Laparoscopy is referred to as a type of surgery in which small incisions are made in the body, such as an abdominal wall, through which, a laparoscope, as well as other instruments, can be placed to allow structures within the internal body cavity to be seen. Robot-assisted laparoscopic surgery helps surgeons to provide improved patient care by converting procedures that would have otherwise been performed by laparotomy into minimally invasive procedures. Robot-assisted laparoscopic surgery has all the advantages of minimally invasive surgery, including less postoperative pain, smaller and possibly more cosmetically appealing incisions, shorter hospital stay, shorter recovery time, and faster return to work. Laparoscopy plays a vital role in performing surgeries in Diabetic patients where minimally invasiveness is crucial.
As per the May 2019 research study published on Frontiers in Pediatrics journal, the study demonstrated that Robot-Assisted Laparoscopic is safe and effective in children. In November 2020, the Asian Congress of Robotic and Laparoscopic Surgery 2020 was held in Seoul, South Korea. The main motto of the conference is to create awareness and benefits about robotic and laparoscopic surgeries in Asian Countries. In February 2021, Cambridge-based medical device company CMR Surgical (CMR) launched Versius Surgical Robotic System to perform minimal access surgery (MAS) which is also known as laparoscopic or keyhole surgeries. Thus, the aforementioned factors are likely to drive the market growth during the forecast period.
North America Dominates the Market and Expected to do Same in the Forecast Period.
North America is expected to dominate the global robotic endoscopy devices market throughout the forecast period. The United States dominates the robotic endoscopy devices market in the North American region and it is expected to continue its stronghold for a few more years. An increasing number of treatments, along with a rising population that exhibits a higher prevalence of gastrointestinal disorders, is driving the growth of the market. Furthermore, colon cancer is projected to be the third-leading cause of cancer deaths in the United States, which is expected to cause about 53,200 deaths during 2020 in the United States, as per the American Cancer Society.
The number of annual gastro-intestinal procedures is also likely to grow, due to the growing prevalence of digestive disorders, increase in preference for minimally invasive surgeries, and rise in the elderly population, and the expanding therapeutic capabilities of endoscopy devices, which are boosting the growth of the market in the United States. According to the World Ageing 2019 report, the United States had about 53.340 million (16.2%) population aged 65 years or over in 2019. This number is projected to reach 70.842 million (20.3%) in 2030.
Key Topics Covered:
1 INTRODUCTION
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Geriatric Population and Rise in Prevalence of Obesity and Diabetes
4.2.2 New Product Launches with Advanced Technologies and Preference for Minimal Invasive Procedures
4.3 Market Restraints
4.3.1 Highly Expensive Surgical Endoscopic Procedures and Troublesome Repayment Approaches
4.3.2 Stringent Regulatory Reforms due to Patient Safety Concerns
4.4 Porter’s Five Force Analysis
5 MARKET SEGMENTATION
5.1 By Product
5.2 By Application
5.3 By End-User
5.4 Geography
6 COMPETITIVE LANDSCAPE
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
For more information about this report visit https://www.researchandmarkets.com/r/gwv6a8
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
